サマリー

This report contains market size and forecasts of Total Intravenous Anesthesia (TIVA) in China, including the following market information:
China Total Intravenous Anesthesia (TIVA) Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Total Intravenous Anesthesia (TIVA) Market Sales, 2016-2021, 2022-2027, (K Units)
China top five Total Intravenous Anesthesia (TIVA) companies in 2020 (%)
The global Total Intravenous Anesthesia (TIVA) market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Total Intravenous Anesthesia (TIVA) market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Total Intravenous Anesthesia (TIVA) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Total Intravenous Anesthesia (TIVA) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
China Total Intravenous Anesthesia (TIVA) Market Segment Percentages, By Type, 2020 (%)
Propofol
Etomidate
Midazolam
Barbiturates
Others

China Total Intravenous Anesthesia (TIVA) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
China Total Intravenous Anesthesia (TIVA) Market Segment Percentages, By Application, 2020 (%)
Predominantly Emergency
Orthopedic
Cosmetic Surgeries
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Total Intravenous Anesthesia (TIVA) revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Total Intravenous Anesthesia (TIVA) revenues share in China market, 2020 (%)
Key companies Total Intravenous Anesthesia (TIVA) sales in China market, 2016-2021 (Estimated), (K Units)
Key companies Total Intravenous Anesthesia (TIVA) sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun Medical
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan

ページTOPに戻る

目次

1 Introduction to Research & Analysis Reports
1.1 Total Intravenous Anesthesia (TIVA) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Total Intravenous Anesthesia (TIVA) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Total Intravenous Anesthesia (TIVA) Overall Market Size
2.1 China Total Intravenous Anesthesia (TIVA) Market Size: 2021 VS 2027
2.2 China Total Intravenous Anesthesia (TIVA) Revenue, Prospects & Forecasts: 2016-2027
2.3 China Total Intravenous Anesthesia (TIVA) Sales: 2016-2027

3 Company Landscape
3.1 Top Total Intravenous Anesthesia (TIVA) Players in China Market
3.2 Top China Total Intravenous Anesthesia (TIVA) Companies Ranked by Revenue
3.3 China Total Intravenous Anesthesia (TIVA) Revenue by Companies
3.4 China Total Intravenous Anesthesia (TIVA) Sales by Companies
3.5 China Total Intravenous Anesthesia (TIVA) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Total Intravenous Anesthesia (TIVA) Companies in China Market, by Revenue in 2020
3.7 Manufacturers Total Intravenous Anesthesia (TIVA) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Total Intravenous Anesthesia (TIVA) Players in China Market
3.8.1 List of Tier 1 Total Intravenous Anesthesia (TIVA) Companies in China
3.8.2 List of Tier 2 and Tier 3 Total Intravenous Anesthesia (TIVA) Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Total Intravenous Anesthesia (TIVA) Market Size Markets, 2021 & 2027
4.1.2 Propofol
4.1.3 Etomidate
4.1.4 Midazolam
4.1.5 Barbiturates
4.1.6 Others
4.2 By Type - China Total Intravenous Anesthesia (TIVA) Revenue & Forecasts
4.2.1 By Type - China Total Intravenous Anesthesia (TIVA) Revenue, 2016-2021
4.2.2 By Type - China Total Intravenous Anesthesia (TIVA) Revenue, 2022-2027
4.2.3 By Type - China Total Intravenous Anesthesia (TIVA) Revenue Market Share, 2016-2027
4.3 By Type - China Total Intravenous Anesthesia (TIVA) Sales & Forecasts
4.3.1 By Type - China Total Intravenous Anesthesia (TIVA) Sales, 2016-2021
4.3.2 By Type - China Total Intravenous Anesthesia (TIVA) Sales, 2022-2027
4.3.3 By Type - China Total Intravenous Anesthesia (TIVA) Sales Market Share, 2016-2027
4.4 By Type - China Total Intravenous Anesthesia (TIVA) Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Total Intravenous Anesthesia (TIVA) Market Size, 2021 & 2027
5.1.2 Predominantly Emergency
5.1.3 Orthopedic
5.1.4 Cosmetic Surgeries
5.1.5 Others
5.2 By Application - China Total Intravenous Anesthesia (TIVA) Revenue & Forecasts
5.2.1 By Application - China Total Intravenous Anesthesia (TIVA) Revenue, 2016-2021
5.2.2 By Application - China Total Intravenous Anesthesia (TIVA) Revenue, 2022-2027
5.2.3 By Application - China Total Intravenous Anesthesia (TIVA) Revenue Market Share, 2016-2027
5.3 By Application - China Total Intravenous Anesthesia (TIVA) Sales & Forecasts
5.3.1 By Application - China Total Intravenous Anesthesia (TIVA) Sales, 2016-2021
5.3.2 By Application - China Total Intravenous Anesthesia (TIVA) Sales, 2022-2027
5.3.3 By Application - China Total Intravenous Anesthesia (TIVA) Sales Market Share, 2016-2027
5.4 By Application - China Total Intravenous Anesthesia (TIVA) Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 B. Braun Medical
6.1.1 B. Braun Medical Corporation Information
6.1.2 B. Braun Medical Overview
6.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.1.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Description
6.1.5 B. Braun Medical Recent Developments
6.2 Astrazeneca
6.2.1 Astrazeneca Corporation Information
6.2.2 Astrazeneca Overview
6.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.2.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Description
6.2.5 Astrazeneca Recent Developments
6.3 Fresenius-Kabi
6.3.1 Fresenius-Kabi Corporation Information
6.3.2 Fresenius-Kabi Overview
6.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.3.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Description
6.3.5 Fresenius-Kabi Recent Developments
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Overview
6.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Description
6.4.5 AbbVie Recent Developments
6.5 Baxter Healthcare
6.5.1 Baxter Healthcare Corporation Information
6.5.2 Baxter Healthcare Overview
6.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.5.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Description
6.5.5 Baxter Healthcare Recent Developments
6.6 Maruishi
6.6.1 Maruishi Corporation Information
6.6.2 Maruishi Overview
6.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.6.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Description
6.6.5 Maruishi Recent Developments
6.7 Piramal
6.7.1 Piramal Corporation Information
6.7.2 Piramal Overview
6.7.3 Piramal Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.7.4 Piramal Total Intravenous Anesthesia (TIVA) Product Description
6.7.5 Piramal Recent Developments
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Overview
6.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.8.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Description
6.8.5 Hikma Pharmaceuticals Recent Developments
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Overview
6.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.9.4 Mylan Total Intravenous Anesthesia (TIVA) Product Description
6.9.5 Mylan Recent Developments
6.10 Nhwa
6.10.1 Nhwa Corporation Information
6.10.2 Nhwa Overview
6.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.10.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Description
6.10.5 Nhwa Recent Developments
6.11 Hengrui
6.11.1 Hengrui Corporation Information
6.11.2 Hengrui Overview
6.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.11.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Description
6.11.5 Hengrui Recent Developments
6.12 Lunan
6.12.1 Lunan Corporation Information
6.12.2 Lunan Overview
6.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales and Revenue in China Market (2016-2021)
6.12.4 Lunan Total Intravenous Anesthesia (TIVA) Product Description
6.12.5 Lunan Recent Developments

7 China Total Intravenous Anesthesia (TIVA) Production Capacity, Analysis
7.1 China Total Intravenous Anesthesia (TIVA) Production Capacity, 2016-2027
7.2 Total Intravenous Anesthesia (TIVA) Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Total Intravenous Anesthesia (TIVA) Supply Chain Analysis
9.1 Total Intravenous Anesthesia (TIVA) Industry Value Chain
9.2 Total Intravenous Anesthesia (TIVA) Upstream Market
9.3 Total Intravenous Anesthesia (TIVA) Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Total Intravenous Anesthesia (TIVA) Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer